The stem cell manufacturing market is projected to reach USD 14.61 billion by 2023 from USD 10.75 billion in 2018, at a CAGR of 6.3%

Tuesday, March 20, 2018 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, March 20, 2018 /PRNewswire/ -- Stem cell manufacturing market projected to grow at a CAGR of 6.3%The stem

cell manufacturing market is projected to reach USD 14.61 billion by 2023 from USD 10.75 billion in 2018, at a CAGR of 6.3%. The growing public-private investments and funding in stem cell-based
research, rising public awareness regarding about the therapeutic potency of stem cell products, and development of advanced genomic analysis techniques for quality control during stem cell manufacturing are the major factors driving the stem cell manufacturing market. Factor such as the significant operational costs associated with stem cell manufacturing and banking is limiting the growth of the market to a certain extent.Read the full report: https://www.reportlinker.com/p05361410 The stem cell line segment is expected to witness the highest growth during the forecast periodOn the basis of product, the stem cell lines segment is expected to register the highest growth rate during the forecast period, due to the growing demand for functionally potent stem cell lines in research and the development of innovative stem cell culture & preservation techniques.The research applications segment accounted for the largest share of the stem cell manufacturing in 2017Based on application, the global stem cell manufacturing market is segmented into research applications, clinical applications, and cell and tissue banking.The research applications segment accounted for the largest share of the stem cell manufacturing in 2017.The growth in this segment is primarily attributed to the increasing focus on stem cell-based research, growing awareness about the therapeutic potency of stem cells, and public-private funding to support product development & commercialization.The cell and tissue banks segment is poised to be the fastest growing during the forecast periodOn the basis of end user, the cell and tissue banks segment is expected to register the highest growth rate during the forecast period, owing to the growing number of stem cell transplantation procedures, ongoing advancements in stem cell & tissue processing and storage methodologies, and growing applications of stem cells in disease treatment.Asia Pacific is expected to register the highest growth rate during the forecast periodGeographically, the stem cell manufacturing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is expected to register the highest growth rate during the forecast period owing to a supportive regulatory framework for stem cell research & manufacturing and ongoing expansion & modernization of healthcare infrastructure across emerging Asian countries.Breakdown of supply-side primary interviews: by company type, designation, and region:• By Company Type - Tier 1 – 48%, Tier 2 – 40% and Tier 3 – 12%• By Designation – C-level – 26%, Director-level – 30%, Others – 44%• By Region – North America - 34%, Europe – 26%, APAC – 23%, and RoW – 17%The global stem cell manufacturing market is competitive, with a large number of global and local players.In 2016, the market was dominated by Thermo Fisher Scientific (US), Merck Group (Germany), and Becton, Dickinson and Company (US).New product launches, upgrades, approvals, agreements, partnerships, and collaborations were the major strategies adopted by market players to achieve growth in the market.Research CoverageThis report studies the stem cell manufacturing market, based on product, application, end user, and region.The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders.Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market.The report forecasts the revenue of the market segments with respect to four main regions.Reasons to Buy the Report:This research report focuses on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the stem cell manufacturing market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn can help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.The report provides insights on the following pointers:• Market Penetration: Comprehensive information on product portfolios offered by the major players in the stem cell manufacturing market. The report analyzes the stem cell manufacturing market based on product, application, end user, and region• New Product Development: Detailed insights on the research and development activities and new product launches in the stem cell manufacturing market• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various stem cell manufacturing products across geographies• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the stem cell manufacturing market• Competitive Assessment: In-depth assessment of market ranking, strategies, product portfolios, distribution networks, and providers capabilities of leading players in the stem cell manufacturing marketRead the full report: https://www.reportlinker.com/p05361410 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com  US: (339)-368-6001 Intl: +1 339-368-6001 

Cision View original content:http://www.prnewswire.com/news-releases/the-stem-cell-manufacturing-market-is-projected-to-reach-usd-1461-billion-by-2023-from-usd-1075-billion-in-2018-at-a-cagr-of-63-300616664.html

SOURCE Reportlinker

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store